Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujing Xin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Gastrointestinal Oncology|November 19, 2020
Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablationYi Yang, Feng Ye, Yujing Xin, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablationYujing Xin, Yi Yang, Ning Liu, et al.
Hepatology International|April 10, 2023
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinomaYujing Xin, Xinyuan Zhang, Ning Liu, et al.
Cardiovascular and Interventional Radiology|September 25, 2021
A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency AblationYujing Xin, Xinyuan Zhang, Ying Li, et al.
Abdominal Radiology (New York)|August 9, 2018
Usefulness of real-time contrast-enhanced ultrasound guided coaxial needle biopsy for focal liver lesionsXiaojing Cao, Zhenxing Liu, Xiang Zhou, et al.
Abdominal Radiology (New York)|April 4, 2025
Diagnostic value of combining ultrafast cine MRI and morphological measurements on gastroesophageal reflux diseaseQing Liu, Yujing Xin, Chao Wu, et al.
European Journal of Radiology|March 12, 2021
Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective studyYi Yang, Yi Chen, Xinyuan Zhang, et al.
Frontiers in Immunology|August 22, 2022
Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinomaYujing Xin, Fei Cao, Hongcai Yang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 7, 2022
Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablationXinyuan Zhang, Yujing Xin, Yi Yang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 16, 2021
Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factorsYi Yang, Yujing Xin, Feng Ye, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal Oncology|November 19, 2020
Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablationYi Yang, Feng Ye, Yujing Xin, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablationYujing Xin, Yi Yang, Ning Liu, et al.
Hepatology International|April 10, 2023
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinomaYujing Xin, Xinyuan Zhang, Ning Liu, et al.
Cardiovascular and Interventional Radiology|September 25, 2021
A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency AblationYujing Xin, Xinyuan Zhang, Ying Li, et al.
Abdominal Radiology (New York)|August 9, 2018
Usefulness of real-time contrast-enhanced ultrasound guided coaxial needle biopsy for focal liver lesionsXiaojing Cao, Zhenxing Liu, Xiang Zhou, et al.
Abdominal Radiology (New York)|April 4, 2025
Diagnostic value of combining ultrafast cine MRI and morphological measurements on gastroesophageal reflux diseaseQing Liu, Yujing Xin, Chao Wu, et al.
European Journal of Radiology|March 12, 2021
Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective studyYi Yang, Yi Chen, Xinyuan Zhang, et al.
Frontiers in Immunology|August 22, 2022
Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinomaYujing Xin, Fei Cao, Hongcai Yang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 7, 2022
Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablationXinyuan Zhang, Yujing Xin, Yi Yang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 16, 2021
Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factorsYi Yang, Yujing Xin, Feng Ye, et al.
Pageof 3